PDCD1 and melanoma: Anti-programmed cell death protein 1 (anti-PD-1) treatment is responsible for long-term clinical improvements in patients diagnosed with advanced melanoma; further, the constitution of the intestinal microbiota is associated with anti-PD-1 efficiency in preclinical models and cancer patients.